CI

At a glance

ClinicalIndex Comparison Record
Phase 1Recruiting· 50 target
Drug / intervention
washed microbiota transplantationdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06376331
NCT06376331Phase 1RecruitingOn TrackUpdated 9mo ago

Washed Microbiota Transplantation for Attention-deficit/Hyperactivity Disorder and Its Comorbidities

The Second Hospital of Nanjing Medical University·interventional·Posted Apr 19, 2024·Updated Sep 5, 2025

In Brief

A Phase 1 clinical trial evaluating washed microbiota transplantation for Attention-deficit/Hyperactivity Disorder. Currently recruiting, targeting 50 participants across 2 sites.

Detailed Summary

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by inattention and hyperactivity-impulsivity. ADHD is often accompanied by oppositional defiant disorder and sleep disturbance, and can increase the risk of other psychiatric disorders, functional impairment in academic and occupational performance. Recently, gut microbiota has been implicated in the ADHD via gut-brain axis. In this study, investigators aimed to evaluate the efficacy of WMT for core ADHD symptoms and its comorbidities using specialized questionnaires for ADHD and investigate the underlying mechanism.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina

Timeline

Phase 1Recruiting
202520262027
First PostedApr 19, 2024
Enrollment StartApr 28, 2024
Primary CompletionJun 1, 2027
Study CompletionJul 1, 2027
TodayJul 1, 2026
Enrollment to primary: 3.1 yearsPosted 2.2 years agoPrimary completion in 11 months

Interventions

washed microbiota transplantationdrug

The prepared microbiota suspension was infused into the participates' lower gut.